PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2022712-6	1991	However, PP secretion in response to the intraduodenal meal or amino acid mixture was abolished after loxiglumide (P less than 0.05).	loxiglumide	102-113	pancreatic polypeptide	Homo sapiens	9-11	
8511500-3	1993	Pretreatment with loxiglumide resulted in a marked increase in CCK-induced gastric acid secretion and abolished the increments in plasma PP without alteration of plasma insulin, glucagon, or somatostatin levels.	loxiglumide	18-29	pancreatic polypeptide	Homo sapiens	137-139	
1752290-8	1991	Meal-stimulated integrated incremental plasma PP concentrations were significantly suppressed (55-65% inhibition, P less than 0.01) by loxiglumide.	loxiglumide	135-146	pancreatic polypeptide	Homo sapiens	46-48	
2022712-9	1991	When CCK-8 was infused with loxiglumide, the insulin and PP responses were similar to the values found with loxiglumide alone.	loxiglumide	28-39	pancreatic polypeptide	Homo sapiens	57-59	
2274676-4	1990	Both loxiglumide and atropine completely abolished the PP response to exogenous or endogenous stimulation (P less than 0.05).	loxiglumide	5-16	pancreatic polypeptide	Homo sapiens	55-57